InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by WILLITS ALAN D, Vice-Président Exécutif, Responsable Commercial. Officer active across 1 company, notably S&W Seed Co. Cumulatively, 4 filings have been recorded. Activity tracked since 15 October 2021. The latest transaction was disclosed on 15 December 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
22,799 shares0Common StockSEC:0001209191-21-070308
22,799 shares0Common StockSEC:0001209191-21-070308:0
366,300 shares@ US$2.735.53% mcap100.0% of flowCommon StockSEC:0001209191-21-060815
366,300 shares@ US$2.735.53% mcap50.0% of flowCommon StockSEC:0001209191-21-060815:0
4 of 4 declarations
About WILLITS ALAN D
Mark Neumann serves as Executive Vice President, Chief Commercial Officer at Intra-Cellular Therapies, Inc. In this role, he oversees the company's commercial activities, including sales development and marketing. Mark plays a key role in implementing commercial strategies that support the company's growth.
